Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Effector Therapeutics Inc (NQ: EFTR )

0.6600 +0.1300 (+24.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,958,043
Open 0.7200
Bid (Size) 0.6601 (1)
Ask (Size) 0.6700 (1)
Prev. Close 0.5300
Today's Range 0.5700 - 0.7400
52wk Range 0.3378 - 2.970
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga

Performance

YTD
+47.98%
+47.98%
1 Month
+31.68%
+31.68%
3 Month
+36.11%
+36.11%
6 Month
+50.41%
+50.41%
1 Year
-69.44%
-69.44%

More News

Read More
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why eFFECTOR Therapeutics Shares Trading Higher Today
Via Benzinga
Recap: eFFECTOR Therapeutics Q1 Earnings
Via Benzinga
eFFECTOR Therapeutics Collaborates With Stanford Medicine Mid-Stage Breast Cancer Study
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2023
Via Benzinga
Why Is Marvell Technology (MRVL) Stock Up 17% Today?
Via InvestorPlace
Why Is Tilray (TLRY) Stock Down 23% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
eFFECTOR Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From eFFECTOR Therapeutics, Inc.
Via GlobeNewswire
Why Is SunCar Technology (SDA) Stock Down 27% Today?
Via InvestorPlace
Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Is eFFECTOR Therapeutics (EFTR) Stock Up 75% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
eFFECTOR Therapeutics Reports Positive Data Updates from Phase 2 Expansion Cohorts Evaluating Zotatifin in Patients with ER+ Metastatic Breast Cancer at the ASCO 2023 Annual Meeting
From eFFECTOR Therapeutics, Inc.
Via GlobeNewswire
3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year
Via InvestorPlace
eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
From eFFECTOR Therapeutics, Inc.
Via GlobeNewswire
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference
From eFFECTOR Therapeutics, Inc.
Via GlobeNewswire
Why Hitek Global Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
eFFECTOR to Present Updated Clinical Data from Phase 2 Expansion Cohorts for Zotatifin in Patients with ER+ Metastatic Breast Cancer at ASCO 2023 Annual Meeting
From eFFECTOR Therapeutics, Inc.
Via GlobeNewswire
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
eFFECTOR Therapeutics to Collaborate with Stanford Medicine on Investigator-Initiated Randomized Phase 2 Study in Patients with ER+ Breast Cancer
From eFFECTOR Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.